Peroxisome Proliferator Receptor alpha Agonist [EPC]

Peroxisome Proliferator Receptor alpha Agonist [EPC] was reported 57191 times

These side effects are most commonly reported by patients taking drugs of the Peroxisome Proliferator Receptor alpha Agonist [EPC] class:

# Drug class Count
0 FATIGUE 3340
1 NAUSEA 3297
2 DIARRHOEA 3259
3 DRUG INEFFECTIVE 2888
4 DYSPNOEA 2378
5 HEADACHE 2274
6 DIZZINESS 2187
7 PAIN 2138
8 OFF LABEL USE 2086
9 ASTHENIA 2070
10 FALL 2045
11 VOMITING 2004
12 ACUTE KIDNEY INJURY 1950
13 ARTHRALGIA 1755
14 CHRONIC KIDNEY DISEASE 1642
15 MALAISE 1599
16 PRURITUS 1597
17 RENAL FAILURE 1559
18 WEIGHT DECREASED 1537
19 DRUG INTERACTION 1470
20 DEATH 1424
21 DECREASED APPETITE 1365
22 MYALGIA 1363
23 BLOOD GLUCOSE INCREASED 1353
24 PAIN IN EXTREMITY 1345
25 COUGH 1308
26 RASH 1282
27 ABDOMINAL PAIN 1268
28 INSOMNIA 1253
29 PNEUMONIA 1249
30 PYREXIA 1207
31 ABDOMINAL PAIN UPPER 1139
32 CONSTIPATION 1114
33 ANXIETY 1095
34 BACK PAIN 1048
35 WEIGHT INCREASED 1005
36 RHABDOMYOLYSIS 952
37 DEPRESSION 949
38 ANAEMIA 931
39 BLOOD PRESSURE INCREASED 917
40 CONDITION AGGRAVATED 912
41 HYPERTENSION 903
42 URINARY TRACT INFECTION 894
43 SOMNOLENCE 892
44 HYPOTENSION 888
45 GAIT DISTURBANCE 871
46 CHEST PAIN 857
47 DEHYDRATION 854
48 MUSCLE SPASMS 848
49 PRODUCT DOSE OMISSION ISSUE 815
50 FEELING ABNORMAL 791
51 MYOCARDIAL INFARCTION 763
52 SEPSIS 740
53 CONFUSIONAL STATE 730
54 OEDEMA PERIPHERAL 720
55 RENAL IMPAIRMENT 707
56 PERIPHERAL SWELLING 701
57 INJECTION SITE PAIN 690
58 FLUSHING 657
59 ABDOMINAL DISCOMFORT 656
60 TREMOR 656
61 RENAL FAILURE ACUTE 652
62 DIABETES MELLITUS 643
63 DRUG HYPERSENSITIVITY 643
64 PANCREATITIS 634
65 VISION BLURRED 629
66 MUSCULAR WEAKNESS 624
67 CHILLS 610
68 ERYTHEMA 594
69 GASTROINTESTINAL HAEMORRHAGE 585
70 ATRIAL FIBRILLATION 583
71 SYNCOPE 581
72 CEREBROVASCULAR ACCIDENT 578
73 NASOPHARYNGITIS 575
74 PARAESTHESIA 574
75 BLOOD TRIGLYCERIDES INCREASED 557
76 CARDIAC FAILURE CONGESTIVE 548
77 HYPOAESTHESIA 548
78 HYPERHIDROSIS 545
79 PSORIASIS 545
80 HYPOGLYCAEMIA 542
81 PRODUCT USE IN UNAPPROVED INDICATION 542
82 ALOPECIA 539
83 DRUG DOSE OMISSION 535
84 COVID-19 530
85 NEUTROPENIA 520
86 SINUSITIS 519
87 MEMORY IMPAIRMENT 516
88 BLOOD CREATININE INCREASED 514
89 GASTROOESOPHAGEAL REFLUX DISEASE 509
90 PANCREATITIS ACUTE 509
91 TOXICITY TO VARIOUS AGENTS 509
92 TACHYCARDIA 503
93 EYE PAIN 499
94 LOSS OF CONSCIOUSNESS 497
95 INCORRECT DOSE ADMINISTERED 484
96 DYSPEPSIA 478
97 HAEMOGLOBIN DECREASED 473
98 WHITE BLOOD CELL COUNT DECREASED 473
99 ABDOMINAL DISTENSION 466
100 BLOOD CHOLESTEROL INCREASED 461
101 HAEMATURIA 459
102 BLOOD CREATINE PHOSPHOKINASE INCREASED 442
103 CONTUSION 437
104 END STAGE RENAL DISEASE 429
105 PULMONARY EMBOLISM 428
106 INFLUENZA 424
107 COMPLETED SUICIDE 418
108 HYPERSENSITIVITY 416
109 URTICARIA 411
110 BALANCE DISORDER 403
111 BRONCHITIS 403
112 PRODUCT USE ISSUE 401
113 CARDIAC FAILURE 399
114 INFECTION 397
115 NEUROPATHY PERIPHERAL 397
116 JOINT SWELLING 389
117 PLATELET COUNT DECREASED 387
118 BLOOD GLUCOSE DECREASED 386
119 OROPHARYNGEAL PAIN 383
120 GLYCOSYLATED HAEMOGLOBIN INCREASED 369
121 PALPITATIONS 365
122 HYPERGLYCAEMIA 363
123 COMA 359
124 HOT FLUSH 359
125 CARDIO-RESPIRATORY ARREST 353
126 RENAL INJURY 353
127 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 349
128 DRY MOUTH 348
129 TYPE 2 DIABETES MELLITUS 345
130 TINNITUS 344
131 HAEMATEMESIS 343
132 PLEURAL EFFUSION 343
133 ARTHRITIS 342
134 ALANINE AMINOTRANSFERASE INCREASED 341
135 HEART RATE INCREASED 341
136 HYPONATRAEMIA 341
137 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 338
138 BLINDNESS 335
139 EPISTAXIS 335
140 INTERNATIONAL NORMALISED RATIO INCREASED 329
141 ASCITES 327
142 EMOTIONAL DISTRESS 327
143 GASTROINTESTINAL DISORDER 326
144 THROMBOCYTOPENIA 323
145 HEPATIC FUNCTION ABNORMAL 322
146 SWELLING 322
147 DYSPHAGIA 320
148 OEDEMA 320
149 PRODUCT QUALITY ISSUE 320
150 FLATULENCE 318
151 ASPARTATE AMINOTRANSFERASE INCREASED 317
152 CHEST DISCOMFORT 316
153 HOSPITALISATION 315
154 LACTIC ACIDOSIS 314
155 OVERDOSE 314
156 HYPERTRIGLYCERIDAEMIA 313
157 CARDIAC DISORDER 310
158 HEPATIC ENZYME INCREASED 310
159 ILLNESS 308
160 DRUG INTOLERANCE 307
161 ALTERED STATE OF CONSCIOUSNESS 304
162 FEELING HOT 300
163 GENERAL PHYSICAL HEALTH DETERIORATION 296
164 VISUAL IMPAIRMENT 295
165 SLEEP DISORDER 293
166 THROMBOSIS 290
167 HYPOKALAEMIA 289
168 DIABETES MELLITUS INADEQUATE CONTROL 288
169 DIPLOPIA 286
170 HAEMORRHAGIC STROKE 286
171 CORONARY ARTERY DISEASE 284
172 DIABETIC KETOACIDOSIS 281
173 DISEASE PROGRESSION 281
174 PRESYNCOPE 281
175 CELLULITIS 280
176 DYSGEUSIA 280
177 HEAD DISCOMFORT 280
178 CATARACT 279
179 HYPERKALAEMIA 278
180 METABOLIC ACIDOSIS 278
181 CARDIAC ARREST 277
182 TREATMENT NONCOMPLIANCE 277
183 NEPHROLITHIASIS 275
184 RHINORRHOEA 275
185 BLOOD PRESSURE DECREASED 274
186 DRY SKIN 274
187 SEIZURE 271
188 RENAL DISORDER 270
189 GENERALISED OEDEMA 268
190 MOBILITY DECREASED 266
191 ASTHMA 265
192 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 265
193 HEPATIC STEATOSIS 263
194 INTENTIONAL PRODUCT MISUSE 263
195 OCULAR DISCOMFORT 262
196 CHOLELITHIASIS 260
197 STRESS 260
198 ACUTE MYOCARDIAL INFARCTION 258
199 LETHARGY 257
200 OXYGEN SATURATION DECREASED 257
201 PRODUCT DOSE OMISSION 257
202 BURNING SENSATION 256
203 RESPIRATORY FAILURE 256
204 DRUG-INDUCED LIVER INJURY 255
205 OSTEOARTHRITIS 255
206 NEPHROGENIC ANAEMIA 254
207 MIGRAINE 251
208 FLUID RETENTION 250
209 HAEMORRHAGE 250
210 HALLUCINATION 247
211 RECTAL HAEMORRHAGE 247
212 MUSCULOSKELETAL STIFFNESS 246
213 NECK PAIN 244
214 IMPAIRED GASTRIC EMPTYING 240
215 BLISTER 239
216 INJECTION SITE HAEMORRHAGE 239
217 MUSCULOSKELETAL PAIN 239
218 PULMONARY OEDEMA 239
219 FEBRILE NEUTROPENIA 235
220 SUICIDAL IDEATION 235
221 AMAUROSIS FUGAX 232
222 BRADYCARDIA 232
223 ANHEDONIA 230
224 DYSPHONIA 227
225 POLLAKIURIA 227
226 SKIN EXFOLIATION 227
227 VERTIGO 227
228 PHOTOPHOBIA 226
229 DEEP VEIN THROMBOSIS 225
230 THERAPY INTERRUPTED 225
231 UNEVALUABLE EVENT 225
232 DYSPNOEA EXERTIONAL 224
233 INFLUENZA LIKE ILLNESS 223
234 SEPTIC SHOCK 222
235 AGITATION 219
236 SWELLING FACE 219
237 INJECTION SITE BRUISING 218
238 MALIGNANT NEOPLASM PROGRESSION 218
239 RASH PRURITIC 218
240 RHEUMATOID ARTHRITIS 218
241 TUBULOINTERSTITIAL NEPHRITIS 217
242 URINARY TRACT DISORDER 215
243 LIVER DISORDER 214
244 UPPER RESPIRATORY TRACT INFECTION 214
245 AMNESIA 211
246 HERPES ZOSTER 211
247 INTENTIONAL PRODUCT USE ISSUE 210
248 HYPERLIPIDAEMIA 208
249 NASAL CONGESTION 207
250 INJURY 205
251 PANCYTOPENIA 204
252 NERVOUSNESS 202
253 INJECTION SITE ERYTHEMA 199
254 HIGH DENSITY LIPOPROTEIN DECREASED 197
255 LIVER FUNCTION TEST ABNORMAL 196
256 WHITE BLOOD CELL COUNT INCREASED 196
257 HAEMATOCHEZIA 195
258 BONE PAIN 193
259 DYSURIA 193
260 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 193
261 WHEEZING 193
262 OSTEOPOROSIS 192
263 DIVERTICULITIS 191
264 LUNG DISORDER 190
265 JAUNDICE 186
266 IRRITABILITY 185
267 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 185
268 TRANSIENT ISCHAEMIC ATTACK 185
269 UNDERDOSE 185
270 BLOOD POTASSIUM DECREASED 183
271 STOMATITIS 183
272 ARTHROPATHY 182
273 ANGINA PECTORIS 180
274 SURGERY 180
275 HYPOXIA 179
276 ANAPHYLACTIC REACTION 178
277 INTESTINAL OBSTRUCTION 178
278 SLEEP APNOEA SYNDROME 178
279 NO ADVERSE EVENT 175
280 INFLAMMATION 174
281 HYPOTHYROIDISM 173
282 INJECTION SITE PRURITUS 173
283 PRODUCTIVE COUGH 172
284 DISCOMFORT 171
285 LEUKOPENIA 171
286 THERAPY CESSATION 169
287 STAPHYLOCOCCAL INFECTION 168
288 BLOOD POTASSIUM INCREASED 167
289 DEVICE ISSUE 166
290 DYSARTHRIA 166
291 INTENTIONAL OVERDOSE 166
292 HYPOPHAGIA 165
293 ANGIOEDEMA 164
294 ADVERSE DRUG REACTION 162
295 DYSKINESIA 161
296 DYSSTASIA 161
297 RED BLOOD CELL COUNT DECREASED 161
298 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 161
299 INTERVERTEBRAL DISC PROTRUSION 160
300 URINARY INCONTINENCE 160
301 BLOOD GLUCOSE ABNORMAL 159
302 PSORIATIC ARTHROPATHY 159
303 RASH ERYTHEMATOUS 159
304 SPEECH DISORDER 159
305 HEAD INJURY 158
306 ECONOMIC PROBLEM 157
307 DRY EYE 156
308 BLOOD PRESSURE SYSTOLIC INCREASED 155
309 GASTRITIS 155
310 MEDICATION ERROR 155
311 ADVERSE EVENT 154
312 BLADDER CANCER 154
313 MYOPATHY 154
314 ARRHYTHMIA 153
315 DISORIENTATION 153
316 INJECTION SITE MASS 153
317 THROAT IRRITATION 153
318 HEART RATE DECREASED 152
319 INFUSION RELATED REACTION 152
320 INTERSTITIAL LUNG DISEASE 151
321 CHROMATURIA 150
322 GAMMA-GLUTAMYLTRANSFERASE INCREASED 149
323 BLOOD UREA INCREASED 148
324 DISTURBANCE IN ATTENTION 148
325 THERAPEUTIC RESPONSE UNEXPECTED 148
326 HEPATIC FAILURE 147
327 COLITIS 146
328 CONVULSION 146
329 HEPATITIS 146
330 ERECTILE DYSFUNCTION 145
331 PRODUCT SUBSTITUTION ISSUE 145
332 DELIRIUM 144
333 EYE IRRITATION 144
334 SUICIDE ATTEMPT 144
335 MENTAL DISORDER 143
336 C-REACTIVE PROTEIN INCREASED 141
337 CYSTITIS 141
338 DEPRESSED MOOD 140
339 LYMPHADENOPATHY 140
340 UNRESPONSIVE TO STIMULI 139
341 ILL-DEFINED DISORDER 138
342 NEPHROPATHY 138
343 SKIN ULCER 138
344 UPPER GASTROINTESTINAL HAEMORRHAGE 138
345 DEVICE MALFUNCTION 136
346 HAEMATOCRIT DECREASED 135
347 PROTEINURIA 135
348 ROAD TRAFFIC ACCIDENT 135
349 VIRAL INFECTION 135
350 HYPOMAGNESAEMIA 133
351 LIMB DISCOMFORT 133
352 SWOLLEN TONGUE 133
353 SKIN LESION 132
354 URINARY RETENTION 132
355 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 131
356 MENTAL STATUS CHANGES 131
357 INJECTION SITE SWELLING 130
358 AGEUSIA 129
359 GASTRIC DISORDER 129
360 GOUT 129
361 HAEMOPTYSIS 129
362 OBESITY 129
363 PERICARDIAL EFFUSION 129
364 HAEMORRHOIDS 128
365 NIGHTMARE 128
366 DISEASE RECURRENCE 127
367 ECZEMA 127
368 HYPERPARATHYROIDISM SECONDARY 127
369 FUNGAL INFECTION 126
370 NIGHT SWEATS 126
371 COGNITIVE DISORDER 125
372 MITRAL VALVE INCOMPETENCE 125
373 RENAL TUBULAR NECROSIS 125
374 HIP FRACTURE 124
375 MELAENA 124
376 CROHN^S DISEASE 123
377 HYPERSOMNIA 123
378 MULTIPLE ORGAN DYSFUNCTION SYNDROME 123
379 DRUG EFFECT DECREASED 122
380 LIMB INJURY 121
381 HAEMATOMA 120
382 HYPERCHOLESTEROLAEMIA 120
383 LOCALISED INFECTION 120
384 MOVEMENT DISORDER 120
385 CORONARY ARTERY OCCLUSION 119
386 SKIN BURNING SENSATION 119
387 SKIN DISCOLOURATION 119
388 THERAPY NON-RESPONDER 119
389 GAIT INABILITY 118
390 TRANSAMINASES INCREASED 118
391 DYSLIPIDAEMIA 117
392 EYE SWELLING 117
393 HYPOACUSIS 117
394 LABORATORY TEST ABNORMAL 117
395 REBOUND ACID HYPERSECRETION 117
396 AGGRESSION 116
397 INCREASED APPETITE 116
398 LOWER RESPIRATORY TRACT INFECTION 116
399 NEURALGIA 116
400 HEPATIC CIRRHOSIS 115
401 THERAPEUTIC RESPONSE DECREASED 115
402 CHOLESTASIS 114
403 GLOMERULAR FILTRATION RATE DECREASED 114
404 ORAL PAIN 114
405 ERUCTATION 113
406 LEUKOCYTOSIS 113
407 MUSCULOSKELETAL CHEST PAIN 113
408 ACUTE RESPIRATORY FAILURE 112
409 BLOOD PRESSURE FLUCTUATION 112
410 APHASIA 111
411 DIABETIC NEUROPATHY 111
412 LACRIMATION INCREASED 110
413 FEELING COLD 107
414 OCULAR HYPERAEMIA 107
415 ORTHOSTATIC HYPOTENSION 107
416 RIB FRACTURE 107
417 WRONG TECHNIQUE IN DRUG USAGE PROCESS 107
418 BONE DENSITY DECREASED 106
419 HALLUCINATION, VISUAL 105
420 HEPATOTOXICITY 105
421 JOINT STIFFNESS 105
422 SHOCK 105
423 DRUG WITHDRAWAL SYNDROME 104
424 OSTEOPENIA 104
425 RENAL FAILURE CHRONIC 104
426 RESPIRATORY TRACT INFECTION 104
427 SINUS DISORDER 104
428 SKIN DISORDER 104
429 ABNORMAL DREAMS 103
430 EUGLYCAEMIC DIABETIC KETOACIDOSIS 103
431 FAECES DISCOLOURED 103
432 HERNIA 103
433 INJECTION SITE REACTION 103
434 MYOSITIS 103
435 PHOTOSENSITIVITY REACTION 103
436 TREATMENT FAILURE 103
437 IMPAIRED HEALING 102
438 NEOPLASM MALIGNANT 102
439 PAIN IN JAW 102
440 WITHDRAWAL SYNDROME 102
441 BLOOD PRESSURE ABNORMAL 101
442 CARDIOMYOPATHY 101
443 NEUTROPHIL COUNT DECREASED 101
444 SINUS CONGESTION 101
445 TASTE DISORDER 101
446 THIRST 101
447 CEREBRAL HAEMORRHAGE 100
448 CRYING 100
449 FOOT FRACTURE 100
450 LOW DENSITY LIPOPROTEIN INCREASED 100
451 SEASONAL ALLERGY 100
452 GASTROENTERITIS VIRAL 99
453 HEART RATE IRREGULAR 99
454 RETCHING 99
455 EAR INFECTION 98
456 ELECTROCARDIOGRAM QT PROLONGED 98
457 MULTIPLE SCLEROSIS RELAPSE 98
458 ABNORMAL BEHAVIOUR 96
459 BASAL CELL CARCINOMA 96
460 PANIC ATTACK 96
461 BLOOD URINE PRESENT 95
462 LEFT VENTRICULAR DYSFUNCTION 95
463 PROCEDURAL PAIN 95
464 PRODUCT DOSE OMISSION IN ERROR 95
465 VISUAL ACUITY REDUCED 95
466 AGRANULOCYTOSIS 94
467 BLOOD ALKALINE PHOSPHATASE INCREASED 94
468 CLOSTRIDIUM DIFFICILE INFECTION 94
469 DRUG LEVEL INCREASED 94
470 FEEDING DISORDER 94
471 DRUG EFFECT INCOMPLETE 93
472 JOINT INJURY 93
473 ANKLE FRACTURE 92
474 ARTERIOSCLEROSIS 92
475 ENCEPHALOPATHY 92
476 INTERVERTEBRAL DISC DEGENERATION 92
477 PALLOR 92
478 PRURITUS GENERALISED 92
479 BLOOD SODIUM DECREASED 91
480 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 91
481 GLAUCOMA 91
482 LYMPHOPENIA 91
483 RESTLESSNESS 91
484 SPINAL FRACTURE 91
485 ANGER 90
486 DEPRESSED LEVEL OF CONSCIOUSNESS 90
487 EATING DISORDER 90
488 KIDNEY INFECTION 90
489 MIDDLE INSOMNIA 90
490 MULTIPLE SCLEROSIS 90
491 MUSCLE ATROPHY 90
492 PULMONARY MASS 90
493 RASH MACULAR 90
494 CARDIOMEGALY 89
495 FEAR 89
496 FULL BLOOD COUNT DECREASED 89
497 INTENTIONAL DOSE OMISSION 88
498 IRON DEFICIENCY ANAEMIA 88
499 PNEUMONITIS 88
500 RESPIRATORY ARREST 88
501 SEROTONIN SYNDROME 88
502 BACK DISORDER 87
503 BLOOD GLUCOSE FLUCTUATION 87
504 CHOLECYSTITIS 87
505 COAGULOPATHY 87
506 EJECTION FRACTION DECREASED 87
507 EMOTIONAL DISORDER 87
508 INJECTION SITE EXTRAVASATION 87
509 LIP SWELLING 87
510 PROSTATE CANCER 87
511 ACTIVITIES OF DAILY LIVING IMPAIRED 86
512 CARPAL TUNNEL SYNDROME 86
513 HEPATIC CYTOLYSIS 86
514 LUNG NEOPLASM MALIGNANT 86
515 MUCOSAL INFLAMMATION 86
516 PRESCRIBED OVERDOSE 86
517 RESPIRATORY DISTRESS 86
518 SUPRAVENTRICULAR TACHYCARDIA 86
519 ABDOMINAL PAIN LOWER 85
520 DRUG DEPENDENCE 85
521 EYE DISORDER 85
522 ILEUS 85
523 OSTEOMYELITIS 85
524 TRICUSPID VALVE INCOMPETENCE 85
525 BLOOD MAGNESIUM DECREASED 84
526 EXPOSURE DURING PREGNANCY 84
527 FIBROMYALGIA 84
528 MULTIPLE FRACTURES 84
529 PULMONARY HYPERTENSION 84
530 ROTATOR CUFF SYNDROME 84
531 SPLENOMEGALY 84
532 ACCIDENTAL EXPOSURE TO PRODUCT 83
533 DERMATITIS ATOPIC 83
534 FACE OEDEMA 83
535 FREQUENT BOWEL MOVEMENTS 83
536 HAIR COLOUR CHANGES 83
537 LIVER INJURY 83
538 MATERNAL EXPOSURE DURING PREGNANCY 83
539 POOR QUALITY SLEEP 83
540 RENAL CYST 83
541 UPPER LIMB FRACTURE 83
542 DIABETIC METABOLIC DECOMPENSATION 82
543 HIATUS HERNIA 82
544 MOOD ALTERED 82
545 PRODUCT STORAGE ERROR 82
546 TARDIVE DYSKINESIA 82
547 ARTERIOSCLEROSIS CORONARY ARTERY 81
548 EAR PAIN 81
549 GASTRIC ULCER 81
550 MOOD SWINGS 81
551 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 81
552 RESTLESS LEGS SYNDROME 81
553 TENDON RUPTURE 81
554 THYROID DISORDER 81
555 RASH PAPULAR 80
556 ABASIA 79
557 ACUTE CORONARY SYNDROME 79
558 BLOOD BILIRUBIN INCREASED 79
559 DEAFNESS 79
560 DIALYSIS 79
561 DIZZINESS POSTURAL 79
562 FEELING JITTERY 79
563 FOETAL EXPOSURE DURING PREGNANCY 79
564 HEPATOMEGALY 79
565 HYPERTHYROIDISM 79
566 BREAST CANCER 78
567 DEMENTIA 78
568 DEVICE LEAKAGE 78
569 EYE PRURITUS 78
570 HALLUCINATION, AUDITORY 78
571 NEEDLE ISSUE 78
572 ACUTE RESPIRATORY DISTRESS SYNDROME 77
573 BLOOD PRESSURE DIASTOLIC DECREASED 77
574 GASTROENTERITIS 77
575 MUSCULOSKELETAL DISCOMFORT 77
576 SKIN LACERATION 77
577 WOUND 77
578 BACK INJURY 76
579 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 76
580 EOSINOPHILIA 76
581 GALLBLADDER DISORDER 76
582 PRODUCT ODOUR ABNORMAL 76
583 RESPIRATORY TRACT CONGESTION 76
584 SCIATICA 76
585 SNEEZING 76
586 SPINAL OSTEOARTHRITIS 76
587 BLOOD IRON DECREASED 75
588 HYPOKINESIA 75
589 LOWER LIMB FRACTURE 75
590 VENTRICULAR TACHYCARDIA 75
591 VITAMIN D DECREASED 75
592 KNEE ARTHROPLASTY 74
593 LEFT VENTRICULAR HYPERTROPHY 74
594 NERVE COMPRESSION 74
595 PNEUMONIA ASPIRATION 74
596 PRODUCT PHYSICAL ISSUE 74
597 RESPIRATORY DISORDER 74
598 VITAMIN D DEFICIENCY 74
599 NERVOUS SYSTEM DISORDER 73
600 NOCTURIA 73
601 PANCREATIC CARCINOMA 73
602 SKIN CANCER 73
603 ACNE 72
604 ATELECTASIS 72
605 COLITIS ULCERATIVE 72
606 DELUSION 72
607 MENTAL IMPAIRMENT 72
608 MULTI-ORGAN FAILURE 72
609 THERAPEUTIC PRODUCT EFFECT DECREASED 72
610 TOOTH DISORDER 72
611 BLOOD COUNT ABNORMAL 71
612 EXPIRED PRODUCT ADMINISTERED 71
613 HAEMODIALYSIS 71
614 IRRITABLE BOWEL SYNDROME 71
615 ORAL HERPES 71
616 CANDIDA INFECTION 70
617 CARDIOVASCULAR DISORDER 70
618 DRUG ADMINISTRATION ERROR 70
619 HEPATOCELLULAR INJURY 70
620 PROSTATIC SPECIFIC ANTIGEN INCREASED 70
621 RASH MACULO-PAPULAR 70
622 SCHIZOPHRENIA 70
623 TOOTHACHE 70
624 BODY HEIGHT DECREASED 69
625 MUSCLE TWITCHING 69
626 NEPHROPATHY TOXIC 69
627 PULMONARY FIBROSIS 69
628 SKIN FISSURES 69
629 THINKING ABNORMAL 69
630 ACCIDENTAL OVERDOSE 68
631 BACTERIAL INFECTION 68
632 CONTRAINDICATED PRODUCT ADMINISTERED 68
633 EXTRA DOSE ADMINISTERED 68
634 LOCAL SWELLING 68
635 PLASMA CELL MYELOMA 68
636 ACUTE MYELOID LEUKAEMIA 67
637 DRUG ERUPTION 67
638 FOURNIER^S GANGRENE 67
639 POST PROCEDURAL COMPLICATION 67
640 RASH GENERALISED 67
641 SMALL INTESTINAL OBSTRUCTION 67
642 SUBDURAL HAEMATOMA 67
643 CEREBRAL INFARCTION 66
644 FEMUR FRACTURE 66
645 ISCHAEMIC STROKE 66
646 BLOOD LACTATE DEHYDROGENASE INCREASED 65
647 DERMATITIS 65
648 GRANULOCYTOPENIA 65
649 HAIR TEXTURE ABNORMAL 65
650 HYPERCALCAEMIA 65
651 IMPAIRED WORK ABILITY 65
652 LIPASE INCREASED 65
653 BURSITIS 64
654 CARDIOGENIC SHOCK 64
655 CHOKING 64
656 EXTRAPYRAMIDAL DISORDER 64
657 MYOCARDIAL ISCHAEMIA 64
658 SINUS TACHYCARDIA 64
659 TOOTH INFECTION 64
660 FLUID OVERLOAD 63
661 HYPOCALCAEMIA 63
662 INJECTION SITE NODULE 63
663 MASS 63
664 NEUROLEPTIC MALIGNANT SYNDROME 63
665 SCAR 63
666 URINE OUTPUT DECREASED 63
667 ACIDOSIS 62
668 EPILEPSY 62
669 HYPOPHOSPHATAEMIA 62
670 MALNUTRITION 62
671 NODULE 62
672 TACHYPNOEA 62
673 UPPER-AIRWAY COUGH SYNDROME 62
674 ABNORMAL LOSS OF WEIGHT 61
675 CAROTID ARTERY STENOSIS 61
676 FLANK PAIN 61
677 PARKINSON^S DISEASE 61
678 TENDONITIS 61
679 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 61
680 BLOOD CHOLESTEROL ABNORMAL 60
681 DIVERTICULUM 60
682 ELECTROCARDIOGRAM ABNORMAL 60
683 EYE INFECTION 60
684 MUSCULOSKELETAL DISORDER 60
685 RALES 60
686 ANAL INCONTINENCE 59
687 ANOREXIA 59
688 CONJUNCTIVITIS 59
689 EYE HAEMORRHAGE 59
690 INCORRECT DRUG ADMINISTRATION DURATION 59
691 MOUTH ULCERATION 59
692 NEOPLASM PROGRESSION 59
693 PANCREATITIS CHRONIC 59
694 STENT PLACEMENT 59
695 BRAIN FOG 58
696 JOINT RANGE OF MOTION DECREASED 58
697 MALIGNANT MELANOMA 58
698 PRE-EXISTING CONDITION IMPROVED 58
699 PRODUCT ADHESION ISSUE 58
700 VENTRICULAR EXTRASYSTOLES 58
701 ATRIAL FLUTTER 57
702 CHOLECYSTECTOMY 57
703 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 57
704 CYST 57
705 HYPOVOLAEMIA 57
706 INCONTINENCE 57
707 METASTASES TO LIVER 57
708 PARALYSIS 57
709 POISONING 57
710 PRODUCT TASTE ABNORMAL 57
711 SKIN HAEMORRHAGE 57
712 TENDERNESS 57
713 DECREASED ACTIVITY 56
714 EXOSTOSIS 56
715 INSURANCE ISSUE 56
716 LIGAMENT SPRAIN 56
717 QUALITY OF LIFE DECREASED 56
718 SEDATION 56
719 SPINAL OPERATION 56
720 ABSCESS 55
721 BONE MARROW FAILURE 55
722 DRUG ABUSE 55
723 DRUG PRESCRIBING ERROR 55
724 IMPAIRED QUALITY OF LIFE 55
725 INITIAL INSOMNIA 55
726 MYOCARDITIS 55
727 NERVE INJURY 55
728 PARANOIA 55
729 PETECHIAE 55
730 PULMONARY CONGESTION 55
731 RENAL PAIN 55
732 THROAT TIGHTNESS 55
733 BLOOD TESTOSTERONE DECREASED 54
734 BODY TEMPERATURE INCREASED 54
735 LIVER FUNCTION TEST INCREASED 54
736 LOWER GASTROINTESTINAL HAEMORRHAGE 54
737 OESOPHAGITIS 54
738 OSTEONECROSIS OF JAW 54
739 PANCREATITIS NECROTISING 54
740 SKIN IRRITATION 54
741 AORTIC ARTERIOSCLEROSIS 53
742 ATRIOVENTRICULAR BLOCK 53
743 BONE DISORDER 53
744 HEPATIC FIBROSIS 53
745 HOSPICE CARE 53
746 JOINT DISLOCATION 53
747 MUSCLE TIGHTNESS 53
748 MYELODYSPLASTIC SYNDROME 53
749 MYOCLONUS 53
750 PERITONITIS 53
751 PREMATURE BABY 53
752 PSYCHOTIC DISORDER 53
753 RED BLOOD CELL SEDIMENTATION RATE INCREASED 53
754 ULCER 53
755 CLOSTRIDIUM DIFFICILE COLITIS 52
756 CORONARY ARTERY STENOSIS 52
757 COVID-19 PNEUMONIA 52
758 DEVICE DIFFICULT TO USE 52
759 GLUCOSE TOLERANCE IMPAIRED 52
760 PNEUMOTHORAX 52
761 PRODUCT ADMINISTRATION ERROR 52
762 ANGINA UNSTABLE 51
763 APHTHOUS ULCER 51
764 BIPOLAR DISORDER 51
765 EMPHYSEMA 51
766 GASTROINTESTINAL PAIN 51
767 GINGIVAL BLEEDING 51
768 HAEMORRHAGIC ANAEMIA 51
769 HYPOTONIA 51
770 INFUSION SITE PAIN 51
771 MAJOR DEPRESSION 51
772 ORTHOPNOEA 51
773 RHINITIS 51
774 WEIGHT FLUCTUATION 51
775 AORTIC VALVE INCOMPETENCE 50
776 ATAXIA 50
777 HEMIPARESIS 50
778 MANIA 50
779 MULTIPLE ALLERGIES 50
780 SHOCK HAEMORRHAGIC 50
781 THERAPEUTIC RESPONSE SHORTENED 50
782 TOOTH ABSCESS 50
783 FRACTURE 49
784 GLOSSODYNIA 49
785 GROIN PAIN 49
786 INTENTIONAL DRUG MISUSE 49
787 INTERNAL HAEMORRHAGE 49
788 LARGE INTESTINE POLYP 49
789 ORAL CANDIDIASIS 49
790 PHARYNGEAL OEDEMA 49
791 PHARYNGITIS 49
792 PSYCHOLOGICAL TRAUMA 49
793 ADRENAL INSUFFICIENCY 48
794 BLINDNESS UNILATERAL 48
795 ELECTROLYTE IMBALANCE 48
796 FOOT DEFORMITY 48
797 HAIR DISORDER 48
798 HUNGER 48
799 INCREASED TENDENCY TO BRUISE 48
800 LYMPHOCYTE COUNT DECREASED 48
801 MADAROSIS 48
802 MICTURITION URGENCY 48
803 ODYNOPHAGIA 48
804 PRESCRIBED UNDERDOSE 48
805 PRODUCT PRESCRIBING ISSUE 48
806 PROSTATOMEGALY 48
807 SCRATCH 48
808 THERAPY PARTIAL RESPONDER 48
809 TOXIC SKIN ERUPTION 48
810 WRIST FRACTURE 48
811 ARTERIAL OCCLUSIVE DISEASE 47
812 BENIGN PROSTATIC HYPERPLASIA 47
813 BLOOD CALCIUM INCREASED 47
814 HEPATITIS CHOLESTATIC 47
815 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 47
816 PEMPHIGOID 47
817 PREMATURE DELIVERY 47
818 RENAL CANCER 47
819 ANAPHYLACTIC SHOCK 46
820 BEDRIDDEN 46
821 BUNDLE BRANCH BLOCK LEFT 46
822 COLON CANCER 46
823 DIASTOLIC DYSFUNCTION 46
824 DRUG DISPENSING ERROR 46
825 ESCHERICHIA URINARY TRACT INFECTION 46
826 HYPERTRANSAMINASAEMIA 46
827 OSTEONECROSIS 46
828 PERIPHERAL VASCULAR DISORDER 46
829 APHONIA 45
830 ATRIOVENTRICULAR BLOCK FIRST DEGREE 45
831 CHRONIC SINUSITIS 45
832 DERMATITIS CONTACT 45
833 GASTROINTESTINAL HYPOMOTILITY 45
834 HEPATITIS ACUTE 45
835 HIP ARTHROPLASTY 45
836 HYDRONEPHROSIS 45
837 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 45
838 PANCREATIC DISORDER 45
839 POLYURIA 45
840 PRODUCT AVAILABILITY ISSUE 45
841 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 45
842 SQUAMOUS CELL CARCINOMA 45
843 VAGINAL HAEMORRHAGE 45
844 BLOOD CREATININE ABNORMAL 44
845 BLOOD TRIGLYCERIDES ABNORMAL 44
846 COLD SWEAT 44
847 DRUG DOSE OMISSION BY DEVICE 44
848 DRUG LEVEL DECREASED 44
849 HYPERKERATOSIS 44
850 HYPOVOLAEMIC SHOCK 44
851 INCORRECT DOSE ADMINISTERED BY DEVICE 44
852 INJECTION SITE RASH 44
853 LACERATION 44
854 NEUTROPHIL COUNT INCREASED 44
855 PLATELET COUNT INCREASED 44
856 POLYMYOSITIS 44
857 PRODUCT DISPENSING ERROR 44
858 SENSORY DISTURBANCE 44
859 TROPONIN INCREASED 44
860 ANURIA 43
861 BOWEL MOVEMENT IRREGULARITY 43
862 CYANOSIS 43
863 FULL BLOOD COUNT ABNORMAL 43
864 HYPERBILIRUBINAEMIA 43
865 HYPERTONIC BLADDER 43
866 IMMUNODEFICIENCY 43
867 IMPAIRED DRIVING ABILITY 43
868 INJECTION SITE URTICARIA 43
869 KETOACIDOSIS 43
870 LYMPHOEDEMA 43
871 MUSCLE DISORDER 43
872 NASAL DISCOMFORT 43
873 PANCREATIC CARCINOMA METASTATIC 43
874 PRODUCT ADMINISTRATION INTERRUPTED 43
875 PULMONARY TOXICITY 43
876 RENAL FUNCTION TEST ABNORMAL 43
877 SUSPECTED SUICIDE 43
878 WHITE BLOOD CELL COUNT ABNORMAL 43
879 APPLICATION SITE ERYTHEMA 42
880 BLOOD TEST ABNORMAL 42
881 BODY TEMPERATURE DECREASED 42
882 CARDIAC MURMUR 42
883 CARDIAC OPERATION 42
884 ESSENTIAL HYPERTENSION 42
885 IMMUNE SYSTEM DISORDER 42
886 INTESTINAL PERFORATION 42
887 LUNG INFILTRATION 42
888 MACULAR DEGENERATION 42
889 PULMONARY THROMBOSIS 42
890 PYELONEPHRITIS 42
891 ABDOMINAL HERNIA 41
892 AORTIC ANEURYSM 41
893 BLADDER DISORDER 41
894 BLOOD CALCIUM DECREASED 41
895 CHOLANGITIS 41
896 DENTAL CARIES 41
897 DILATATION VENTRICULAR 41
898 DRUG LEVEL BELOW THERAPEUTIC 41
899 ECCHYMOSIS 41
900 FAECES SOFT 41
901 GASTRIC ULCER HAEMORRHAGE 41
902 MENISCUS INJURY 41
903 NASAL DRYNESS 41
904 POLYDIPSIA 41
905 POLYP 41
906 VULVOVAGINAL PRURITUS 41
907 BLOOD PRESSURE SYSTOLIC ABNORMAL 40
908 CONCUSSION 40
909 DIARRHOEA HAEMORRHAGIC 40
910 DRUG RESISTANCE 40
911 HYPERNATRAEMIA 40
912 METABOLIC SYNDROME 40
913 METASTASES TO BONE 40
914 PARANASAL SINUS DISCOMFORT 40
915 PELVIC PAIN 40
916 PHARYNGEAL SWELLING 40
917 RESPIRATORY RATE INCREASED 40
918 SARS-COV-2 TEST POSITIVE 40
919 DISSEMINATED INTRAVASCULAR COAGULATION 39
920 DIVERTICULUM INTESTINAL 39
921 KIDNEY FIBROSIS 39
922 NO THERAPEUTIC RESPONSE 39
923 NORMOCHROMIC NORMOCYTIC ANAEMIA 39
924 OLIGURIA 39
925 PURPURA 39
926 SALIVARY HYPERSECRETION 39
927 ACCIDENTAL EXPOSURE 38
928 DYSTONIA 38
929 GYNAECOMASTIA 38
930 HAEMOGLOBIN ABNORMAL 38
931 MITRAL VALVE DISEASE 38
932 MUSCLE STRAIN 38
933 MYELOSUPPRESSION 38
934 NECROTISING FASCIITIS 38
935 NEOPLASM 38
936 NEUROTOXICITY 38
937 PANCREATITIS RELAPSING 38
938 PHARMACEUTICAL PRODUCT COMPLAINT 38
939 PRODUCT USE COMPLAINT 38
940 ANOSMIA 37
941 APPLICATION SITE PAIN 37
942 CAROTID ARTERY OCCLUSION 37
943 DIABETIC RETINOPATHY 37
944 DISABILITY 37
945 DISTRIBUTIVE SHOCK 37
946 DUODENITIS 37
947 INCORRECT ROUTE OF DRUG ADMINISTRATION 37
948 LARYNGITIS 37
949 POLYNEUROPATHY 37
950 SLUGGISHNESS 37
951 SPINAL PAIN 37
952 TOOTH EXTRACTION 37
953 TOOTH FRACTURE 37
954 TRANSFUSION 37
955 AUTOIMMUNE HEPATITIS 36
956 BLOOD THYROID STIMULATING HORMONE INCREASED 36
957 CHOKING SENSATION 36
958 CORONARY ARTERY BYPASS 36
959 DERMATITIS ALLERGIC 36
960 EOSINOPHIL COUNT INCREASED 36
961 HAEMORRHAGE INTRACRANIAL 36
962 HYPERTENSIVE CRISIS 36
963 INFLAMMATORY BOWEL DISEASE 36
964 JAUNDICE CHOLESTATIC 36
965 METABOLIC DISORDER 36
966 NEUROLOGICAL SYMPTOM 36
967 ORAL DISCOMFORT 36
968 PARAESTHESIA ORAL 36
969 PERIPHERAL COLDNESS 36
970 PROTHROMBIN TIME PROLONGED 36
971 RHINALGIA 36
972 SPINAL DISORDER 36
973 TOOTH LOSS 36
974 TOXIC EPIDERMAL NECROLYSIS 36
975 UROSEPSIS 36
976 APPLICATION SITE PRURITUS 35
977 CARDIAC PACEMAKER INSERTION 35
978 CEREBRAL ATROPHY 35
979 CIRCULATORY COLLAPSE 35
980 DEVICE RELATED INFECTION 35
981 DRUG TOXICITY 35
982 FAECALOMA 35
983 FORMICATION 35
984 HAEMORRHOIDAL HAEMORRHAGE 35
985 HEPATIC NECROSIS 35
986 HYPOAESTHESIA ORAL 35
987 INCORRECT PRODUCT ADMINISTRATION DURATION 35
988 PAIN OF SKIN 35
989 PANCREATITIS HAEMORRHAGIC 35
990 POISONING DELIBERATE 35
991 PRODUCT PRESCRIBING ERROR 35
992 RHINITIS ALLERGIC 35
993 SCAB 35
994 SKIN ABRASION 35
995 SKIN INFECTION 35
996 SYNOVIAL CYST 35
997 ULCER HAEMORRHAGE 35
998 URINE ODOUR ABNORMAL 35
999 AKATHISIA 34